NCT00616720View on ClinicalTrials.gov

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

idiotype-pulsed autologous dendritic cell vaccine APC8020

BIOLOGICAL

recombinant interferon gamma

GENETIC

polymerase chain reaction

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

flow cytometry

OTHER

laboratory biomarker analysis

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER